Dysfunction of G protein-coupled receptor kinases in Alzheimer's disease

TheScientificWorldJournal

Volumn 10, Issue , 2010, Pages 1667-1678

  Suo, William Z ^a,b   Li, Longxuan ^a  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

Author keywords

amyloid; Aging; Alzheimer's disease; Cholinergic; G protein coupled receptor kinase (GRK); Muscarinic; Receptor desensitization; Transgenic mice

Indexed keywords

ACETYLCHOLINE; AMYLOID BETA PROTEIN; AUTORECEPTOR; G PROTEIN COUPLED RECEPTOR; G PROTEIN COUPLED RECEPTOR KINASE; G PROTEIN COUPLED RECEPTOR KINASE 2; G PROTEIN COUPLED RECEPTOR KINASE 3; G PROTEIN COUPLED RECEPTOR KINASE 4; G PROTEIN COUPLED RECEPTOR KINASE 5; G PROTEIN COUPLED RECEPTOR KINASE 6; GUANINE NUCLEOTIDE BINDING PROTEIN; RHODOPSIN KINASE;

ALZHEIMER DISEASE; AMNESIA; CHOLINERGIC SYSTEM; COGNITION; DISEASE EXACERBATION; ENCEPHALITIS; FOREBRAIN; HUMAN; NERVE DEGENERATION; NERVE FIBER; NEUROTRANSMITTER RELEASE; NONHUMAN; PATHOGENESIS; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RECEPTOR DOWN REGULATION; REVIEW; SIGNAL TRANSDUCTION; SYNAPSE; AGING; BIOLOGICAL MODEL; CELL MEMBRANE; CYTOSOL; METABOLISM; PATHOLOGY;

MUS MUSCULUS;

AGING; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; CELL MEMBRANE; CYTOSOL; G-PROTEIN-COUPLED RECEPTOR KINASE 2; G-PROTEIN-COUPLED RECEPTOR KINASE 5; HUMANS; MODELS, BIOLOGICAL; SIGNAL TRANSDUCTION;

EID: 78349301261     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2010.154     Document Type: Review

References (82)

1. Duyckaerts, C., Delatour, B., and Potier, M.C. (2009) Classification and basic pathology of Alzheimer disease. Acta Neuropathol. 118, 5-36.
2. Nelson, P.T., Braak, H., and Markesbery, W.R. (2009) Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship. J. Neuropathol. Exp. Neurol. 68, 1-14.
3. Jellinger, K.A. and Bancher, C. (1998) Neuropathology of Alzheimer's disease: a critical update. J. Neural Transm. Suppl. 54, 77-95.
4. Mahler, M.E. and Cummings, J.L. (1990) Alzheimer disease and the dementia of Parkinson disease: comparative investigations. Alzheimer Dis. Assoc. Disord. 4, 133-149.
5. Buee, L., Bussiere, T., Buee-Scherrer, V., Delacourte, A., and Hof, P.R. (2000) Tau protein isoforms, phosphorylation and role in neurodegenerative disorders. Brain Res. Brain Res. Rev. 33, 95-130.
6. Hardy, J. and Selkoe, D.J. (2002) The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science 297, 353-356. (Pubitemid 34790756)
7. McGeer, P.L. and McGeer, E.G. (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22, 799-809.
8. Saitoh, T., Horsburgh, K., and Masliah, E. (1993) Hyperactivation of signal transduction systems in Alzheimer's disease. Ann. N. Y. Acad. Sci. 695, 34-41.
9. Fowler, C.J., Cowburn, R.F., Garlind, A., Winblad, B., and O'Neill, C. (1995) Disturbances in signal transduction mechanisms in Alzheimer's disease. Mol. Cell. Biochem. 149-150, 287-292.
10. Joseph, J.A., Cutler, R., and Roth, G.S. (1993) Changes in G protein-mediated signal transduction in aging and Alzheimer's disease. Ann. N. Y. Acad. Sci. 695, 42-45.
11. Shimohama, S., Fujimoto, S., Tresser, N., Richey, P., Perry, G., Whitehouse, P.J., Homma, Y., Takenawa, T., Taniguchi, T., Suenaga, T., et al. (1993) Aberrant phosphoinositide metabolism in Alzheimer's disease. Ann. N. Y. Acad. Sci. 695, 46-49. (Pubitemid 23348234)
12. Matsushima, H., Shimohama, S., Chachin, M., Taniguchi, T., and Kimura, J. (1996) Ca2+-dependent and Ca2+- independent protein kinase C changes in the brain of patients with Alzheimer's disease. J. Neurochem. 67, 317-323. (Pubitemid 26185612)
13. Mattson, M.P. and Chan, S.L. (2001) Dysregulation of cellular calcium homeostasis in Alzheimer's disease: bad genes and bad habits. J. Mol. Neurosci. 17, 205-224.
14. Fowler, C.J., Garlind, A., O'Neill, C., and Cowburn, R.F. (1996) Receptor-effector coupling dysfunctions in Alzheimer's disease. Ann. N. Y. Acad. Sci. 786, 294-304.
15. Premont, R.T., Inglese, J., and Lefkowitz, R.J. (1995) Protein kinases that phosphorylate activated G protein-coupled receptors. FASEB J. 9, 175-182.
16. Sallese, M., Mariggio, S., Collodel, G., Moretti, E., Piomboni, P., Baccetti, B., and De Blasi, A. (1997) G proteincoupled receptor kinase GRK4. Molecular analysis of the four isoforms and ultrastructural localization in spermatozoa and germinal cells. J. Biol. Chem. 272, 10188-10195.
17. Virlon, B., Firsov, D., Cheval, L., Reiter, E., Troispoux, C., Guillou, F., and Elalouf, J.M. (1998) Rat G protein-coupled receptor kinase GRK4: identification, functional expression, and differential tissue distribution of two splice variants. Endocrinology 139, 2784-2795. (Pubitemid 28512387)
18. Sallese, M., Salvatore, L., D'Urbano, E., Sala, G., Storto, M., Launey, T., Nicoletti, F., Knopfel, T., and De Blasi, A. (2000) The G-protein-coupled receptor kinase GRK4 mediates homologous desensitization of metabotropic glutamate receptor 1. FASEB J. 14, 2569-2580.
19. Kohout, T.A. and Lefkowitz, R.J. (2003) Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol. Pharmacol. 63, 9-18. (Pubitemid 36043803)
20. Pitcher, J.A., Freedman, N.J., and Lefkowitz, R.J. (1998) G protein-coupled receptor kinases. Annu. Rev. Biochem. 67, 653-692.
21. Ribas, C., Penela, P., Murga, C., Salcedo, A., Garcia-Hoz, C., Jurado-Pueyo, M., Aymerich, I., and Mayor, F., Jr. (2007) The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim. Biophys. Acta 1768, 913-922.
22. Jaber, M., Koch, W.J., Rockman, H., Smith, B., Bond, R.A., Sulik, K.K., Ross, J., Jr., Lefkowitz, R.J., Caron, M.G., and Giros, B. (1996) Essential role of beta-adrenergic receptor kinase 1 in cardiac development and function. Proc. Natl. Acad. Sci. U. S. A. 93, 12974-12979.
23. Peppel, K., Boekhoff, I., McDonald, P., Breer, H., Caron, M.G., and Lefkowitz, R.J. (1997) G protein-coupled receptor kinase 3 (GRK3) gene disruption leads to loss of odorant receptor desensitization. J. Biol. Chem. 272, 25425-25428. (Pubitemid 27438843)
24. Gainetdinov, R.R., Bohn, L.M., Walker, J.K., Laporte, S.A., Macrae, A.D., Caron, M.G., Lefkowitz, R.J., and Premont, R.T. (1999) Muscarinic supersensitivity and impaired receptor desensitization in G protein-coupled receptor kinase 5-deficient mice. Neuron 24, 1029-1036.
25. Gainetdinov, R.R., Bohn, L.M., Sotnikova, T.D., Cyr, M., Laakso, A., Macrae, A.D., Torres, G.E., Kim, K.M., Lefkowitz, R.J., Caron, M.G., and Premont, R.T. (2003) Dopaminergic supersensitivity in g protein-coupled receptor kinase 6-deficient mice. Neuron 38, 291-303. (Pubitemid 36555654)
26. Pronin, A.N., Morris, A.J., Surguchov, A., and Benovic, J.L. (2000) Synucleins are a novel class of substrates for G protein-coupled receptor kinases. J. Biol. Chem. 275, 26515-26522.
27. Sorriento, D., Ciccarelli, M., Santulli, G., Campanile, A., Altobelli, G.G., Cimini, V., Galasso, G., Astone, D., Piscione, F., Pastore, L., Trimarco, B., and Iaccarino, G. (2008) The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc. Natl. Acad. Sci. U. S. A. 105, 17818-17823.
28. Sorriento, D., Campanile, A., Santulli, G., Leggiero, E., Pastore, L., Trimarco, B., and Iaccarino, G. (2009) A new synthetic protein, TAT-RH, inhibits tumor growth through the regulation of NFkappaB activity. Mol. Cancer 8, 97.
29. Pitcher, J.A., Fredericks, Z.L., Stone, W.C., Premont, R.T., Stoffel, R.H., Koch, W.J., and Lefkowitz, R.J. (1996) Phosphatidylinositol 4,5-bisphosphate (PIP2)-enhanced G protein-coupled receptor kinase (GRK) activity. Location, structure, and regulation of the PIP2 binding site distinguishes the GRK subfamilies. J. Biol. Chem. 271, 24907-24913.
30. Pronin, A.N., Satpaev, D.K., Slepak, V.Z., and Benovic, J.L. (1997) Regulation of G protein-coupled receptor kinases by calmodulin and localization of the calmodulin binding domain. J. Biol. Chem. 272, 18273-18280. (Pubitemid 27306417)
31. Sallese, M., Iacovelli, L., Cumashi, A., Capobianco, L., Cuomo, L., and De Blasi, A. (2000) Regulation of G proteincoupled receptor kinase subtypes by calcium sensor proteins. Biochim. Biophys. Acta 1498, 112-121.
32. Carman, C.V., Lisanti, M.P., and Benovic, J.L. (1999) Regulation of G protein-coupled receptor kinases by caveolin. J. Biol. Chem. 274, 8858-8864.
33. Suo, Z., Wu, M., Citron, B.A., Wong, G.T., and Festoff, B.W. (2004) Abnormality of G-protein-coupled receptor kinases at prodromal and early stages of Alzheimer's disease: an association with early beta-amyloid accumulation. J. Neurosci. 24, 3444-3452. (Pubitemid 38451910)
34. Suo, Z., Wu, M., Citron, B.A., Wong, G.T., and Festoff, B.W. (2005) Deficiency of G-protein coupled receptor kinases at early stages of Alzheimer's disease: an association with mild to moderate β-amyloid accumulation. Neurobiol. Aging 25, S2-291.
35. Obrenovich, M.E., Smith, M.A., Siedlak, S.L., Chen, S.G., de la Torre, J.C., Perry, G., and Aliev, G. (2006) Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox. Res. 10, 43-56.
36. Takahashi, M., Uchikado, H., Caprotti, D., Weidenheim, K.M., Dickson, D.W., Ksiezak-Reding, H., and Pasinetti, G.M. (2006) Identification of G-protein coupled receptor kinase 2 in paired helical filaments and neurofibrillary tangles. J. Neuropathol. Exp. Neurol. 65, 1157-1169. (Pubitemid 44885940)
37. Leosco, D., Fortunato, F., Rengo, G., Iaccarino, G., Sanzari, E., Golino, L., Zincarelli, C., Canonico, V., Marchese, M., Koch, W.J., and Rengo, F. (2007) Lymphocyte G-protein-coupled receptor kinase-2 is upregulated in patients with Alzheimer's disease. Neurosci. Lett. 415, 279-282.
38. Rockman, H.A., Choi, D.J., Akhter, S.A., Jaber, M., Giros, B., Lefkowitz, R.J., Caron, M.G., and Koch, W.J. (1998) Control of myocardial contractile function by the level of beta-adrenergic receptor kinase 1 in gene-targeted mice. J. Biol. Chem. 273, 18180-18184.
39. Koch, W.J., Rockman, H.A., Samama, P., Hamilton, R.A., Bond, R.A., Milano, C.A., and Lefkowitz, R.J. (1995) Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science 268, 1350-1353.
40. Eckhart, A.D., Ozaki, T., Tevaearai, H., Rockman, H.A., and Koch, W.J. (2002) Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol. Pharmacol. 61, 749-758.
41. Obrenovich, M.E., Morales, L.A., Cobb, C.J., Shenk, J.C., Mendez, G.M., Fischbach, K., Smith, M.A., Qasimov, E.K., Perry, G., and Aliev, G. (2009) Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation. J. Cell. Mol. Med. 13, 853-865.
42. Rockman, H.A., Choi, D.J., Rahman, N.U., Akhter, S.A., Lefkowitz, R.J., and Koch, W.J. (1996) Receptor-specific in vivo desensitization by the G protein-coupled receptor kinase-5 in transgenic mice. Proc. Natl. Acad. Sci. U. S. A. 93, 9954-9959.
43. Suo, Z., Cox, A.A., Bartelli, N., Rasul, I., Festoff, B.W., Premont, R.T., and Arendash, G.W. (2007) GRK5 deficiency leads to early Alzheimer-like pathology and working memory impairment. Neurobiol. Aging 28, 1873-1888. (Pubitemid 47539698)
44. Li, L., Rasul, I., Liu, J., Zhao, B., Tang, R., Premont, R.T., and Suo, W.Z. (2009) Augmented axonal defects and synaptic degenerative changes in female GRK5 deficient mice. Brain Res. Bull. 78, 145-151.
45. Liu, J., Rasul, I., Sun, Y., Wu, G., Li, L., Premont, R.T., and Suo, W.Z. (2009) GRK5 deficiency leads to reduced hippocampal acetylcholine level via impaired presynaptic M2/M4 autoreceptor desensitization. J. Biol. Chem. 284, 19564-19571.
46. Levey, A.I. (1996) Muscarinic acetylcholine receptor expression in memory circuits: implications for treatment of Alzheimer disease. Proc. Natl. Acad. Sci. U. S. A. 93, 13541-13546.
47. Zhang, W., Basile, A.S., Gomeza, J., Volpicelli, L.A., Levey, A.I., and Wess, J. (2002) Characterization of central inhibitory muscarinic autoreceptors by the use of muscarinic acetylcholine receptor knock-out mice. J. Neurosci. 22, 1709-1717. (Pubitemid 35386289)
48. Budd, D.C., McDonald, J., Emsley, N., Cain, K., and Tobin, A.B. (2003) The C-terminal tail of the M3-muscarinic receptor possesses anti-apoptotic properties. J. Biol. Chem. 278, 19565-19573.
49. Postina, R. (2008) A closer look at alpha-secretase. Curr. Alzheimer Res. 5, 179-186.
50. Rossner, S., Ueberham, U., Schliebs, R., Perez-Polo, J.R., and Bigl, V. (1998) The regulation of amyloid precursor protein metabolism by cholinergic mechanisms and neurotrophin receptor signaling. Prog. Neurobiol. 56, 541-569.
51. Sadot, E., Gurwitz, D., Barg, J., Behar, L., Ginzburg, I., and Fisher, A. (1996) Activation of m1 muscarinic acetylcholine receptor regulates tau phosphorylation in transfected PC12 cells. J. Neurochem. 66, 877-880. (Pubitemid 2615766)
52. McKinney, M. and Jacksonville, M.C. (2005) Brain cholinergic vulnerability: relevance to behavior and disease. Biochem. Pharmacol. 70, 1115-1124.
53. Pemberton, K.E., Hill-Eubanks, L.J., and Jones, S.V. (2000) Modulation of low-threshold T-type calcium channels by the five muscarinic receptor subtypes in NIH 3T3 cells. Pflugers Arch. 440, 452-461.
54. Crespo, P., Xu, N., Simonds, W.F., and Gutkind, J.S. (1994) Ras-dependent activation of MAP kinase pathway mediated by G-protein beta gamma subunits. Nature 369, 418-420.
55. Kim, S.S., Choi, J.M., Kim, J.W., Ham, D.S., Ghil, S.H., Kim, M.K., Kim-Kwon, Y., Hong, S.Y., Ahn, S.C., Kim, S.U., Lee, Y.D., and Suh-Kim, H. (2005) cAMP induces neuronal differentiation of mesenchymal stem cells via activation of extracellular signal-regulated kinase/MAPK. Neuroreport 16, 1357-1361.
56. Kiermayer, S., Biondi, R.M., Imig, J., Plotz, G., Haupenthal, J., Zeuzem, S., and Piiper, A. (2005) Epac activation converts cAMP from a proliferative into a differentiation signal in PC12 cells. Mol. Biol. Cell 16, 5639-5648.
57. Malbon, C.C., Tao, J., and Wang, H.Y. (2004) AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes. Biochem. J. 379, 1-9.
58. Tasken, K. and Aandahl, E.M. (2004) Localized effects of cAMP mediated by distinct routes of protein kinase A. Physiol. Rev. 84, 137-167.
59. Dumaz, N. and Marais, R. (2005) Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. Based on the anniversary prize of the Gesellschaft fur Biochemie und Molekularbiologie Lecture delivered on 5 July 2003 at the Special FEBS Meeting in Brussels. FEBS J. 272, 3491-3504.
60. Chin, P.C., Majdzadeh, N., and D'Mello, S.R. (2005) Inhibition of GSK3beta is a common event in neuroprotection by different survival factors. Brain Res. Mol. Brain Res. 137, 193-201.
61. Li, L., Liu, J., and Suo, W.Z. (2008) GRK5 deficiency exaggerates inflammatory changes in TgAPPsw mice. J. Neuroinflammation 5, 24.
62. Le, Y., Gong, W., Tiffany, H.L., Tumanov, A., Nedospasov, S., Shen, W., Dunlop, N.M., Gao, J.L., Murphy, P.M., Oppenheim, J.J., and Wang, J.M. (2001) Amyloid (beta)42 activates a G-protein-coupled chemoattractant receptor, FPR-like-1. J. Neurosci. 21, RC123.
63. Yazawa, H., Yu, Z.X., Takeda, Le, Y., Gong, W., Ferrans, V.J., Oppenheim, J.J., Li, C.C., and Wang, J.M. (2001) Beta amyloid peptide (Abeta42) is internalized via the G-protein-coupled receptor FPRL1 and forms fibrillar aggregates in macrophages. FASEB J. 15, 2454-2462.
64. van Beek, J., Elward, K., and Gasque, P. (2003) Activation of complement in the central nervous system: roles in neurodegeneration and neuroprotection. Ann. N. Y. Acad. Sci. 992, 56-71.
65. Fiala, M., Zhang, L., Gan, X., Sherry, B., Taub, D., Graves, M.C., Hama, S., Way, D., Weinand, M., Witte, M., Lorton, D., Kuo, Y.M., and Roher, A.E. (1998) Amyloid-beta induces chemokine secretion and monocyte migration across a human blood - brain barrier model. Mol. Med. 4, 480-489.
66. Streit, W.J., Conde, J.R., and Harrison, J.K. (2001) Chemokines and Alzheimer's disease. Neurobiol. Aging 22, 909-913.
67. Halks-Miller, M., Schroeder, M.L., Haroutunian, V., Moenning, U., Rossi, M., Achim, C., Purohit, D., Mahmoudi, M., and Horuk, R. (2003) CCR1 is an early and specific marker of Alzheimer's disease. Ann. Neurol. 54, 638-646.
68. Langkabel, P., Zwirner, J., and Oppermann, M. (1999) Ligand-induced phosphorylation of anaphylatoxin receptors C3aR and C5aR is mediated by "G protein-coupled receptor kinases. Eur. J. Immunol. 29, 3035-3046.
69. Oppermann, M., Mack, M., Proudfoot, A.E., and Olbrich, H. (1999) Differential effects of CC chemokines on CC chemokine receptor 5 (CCR5) phosphorylation and identification of phosphorylation sites on the CCR5 carboxyl terminus. J. Biol. Chem. 274, 8875-8885.
70. Fong, A.M., Premont, R.T., Richardson, R.M., Yu, Y.R., Lefkowitz, R.J., and Patel, D.D. (2002) Defective lymphocyte chemotaxis in beta-arrestin2- and GRK6-deficient mice. Proc. Natl. Acad. Sci. U. S. A. 99, 7478-7483.
71. Thathiah, A. and De Strooper, B. (2009) G protein-coupled receptors, cholinergic dysfunction, and Abeta toxicity in Alzheimer's disease. Sci Signal 2, re8.
72. Bartus, R.T., Dean, R.L., 3rd, Beer, B., and Lippa, A.S. (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
73. Bartus, R.T., Dean, R.L., Pontecorvo, M.J., and Flicker, C. (1985) The cholinergic hypothesis: a historical overview, current perspective, and future directions. Ann. N. Y. Acad. Sci. 444, 332-358.
74. Woolf, N.J. (1996) The critical role of cholinergic basal forebrain neurons in morphological change and memory encoding: a hypothesis. Neurobiol. Learn. Mem. 66, 258-266.
75. Ladner, C.J. and Lee, J.M. (1998) Pharmacological drug treatment of Alzheimer disease: the cholinergic hypothesis revisited. J. Neuropathol. Exp. Neurol. 57, 719-731.
76. Fisher, A. (2008) Cholinergic treatments with emphasis on m1 muscarinic agonists as potential disease-modifying agents for Alzheimer's disease. Neurotherapeutics 5, 433-442.
77. Small, D.H. and Cappai, R. (2006) Alois Alzheimer and Alzheimer's disease: a centennial perspective. J. Neurochem. 99, 708-710.
78. De Strooper, B., Vassar, R., and Golde, T. (2010) The secretases: enzymes with therapeutic potential in Alzheimer disease. Nat. Rev. Neurol. 6, 99-107.
79. DeLapp, N., Wu, S., Belagaje, R., Johnstone, E., Little, S., Shannon, H., Bymaster, F., Calligaro, D., Mitch, C., Whitesitt, C., Ward, J., Sheardown, M., Fink-Jensen, A., Jeppesen, L., Thomsen, C., and Sauerberg, P. (1998) Effects of the M1 agonist xanomeline on processing of human beta-amyloid precursor protein (FAD, Swedish mutant) transfected into Chinese hamster ovary-m1 cells. Biochem. Biophys. Res. Commun. 244, 156-160.
80. Lin, L., Georgievska, B., Mattsson, A., and Isacson, O. (1999) Cognitive changes and modified processing of amyloid precursor protein in the cortical and hippocampal system after cholinergic synapse loss and muscarinic receptor activation. Proc. Natl. Acad. Sci. U. S. A. 96, 12108-12113.
81. Fisher, A., Pittel, Z., Haring, R., Bar-Ner, N., Kliger-Spatz, M., Natan, N., Egozi, I., Sonego, H., Marcovitch, I., and Brandeis, R. (2003) M1 muscarinic agonists can modulate some of the hallmarks in Alzheimer's disease: implications in future therapy. J. Mol. Neurosci. 20, 349-356.
82. Liskowsky, W. and Schliebs, R. (2006) Muscarinic acetylcholine receptor inhibition in transgenic Alzheimer-like Tg2576 mice by scopolamine favours the amyloidogenic route of processing of amyloid precursor protein. Int. J. Dev. Neurosci. 24, 149-156.